Overview

Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

Randomized Study of Customized Adjuvant Chemotherapy based on BRCA1 mRNA Levels in Completely Resected stages II-IIIA Non-Small-Cell Lung Cancer Patients.

Phase:

Phase 3

Details

Lead Sponsor:

Spanish Lung Cancer Group

Treatments:

Cisplatin
Docetaxel
Gemcitabine